Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 504)
Posted On: 10/10/2024 12:31:31 AM
Post# of 154155
Posted By: My69z
Re: My69z #147057
Dan H. Barouch -- director of the CVVR and professor of medicine at Harvard Medical School, is an innovator in the field of infectious disease research. His research group and partners have developed a new HIV vaccine candidate that is currently being tested in humans. This vaccine candidate induces a robust immune response, and it has advanced into a large-scale Phase 2B human efficacy trial in Africa and a large-scale Phase 3 licensure efficacy trial in the Americas and Europe in partnership with the U.S. National Institutes of Health, the HIV Vaccine Trials Network, the Bill & Melinda Gates Foundation, Janssen, and other entities.

https://www.bidmc.org/research/research-by-de...laboratory
___
Future successes speak ---- LL-PLS & these 2 bNab's, combined with Dr. Barouch & his multiple collaborators vaccine:

No more HIV in any scenario













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site